全文获取类型
收费全文 | 1468331篇 |
免费 | 129282篇 |
国内免费 | 4383篇 |
专业分类
耳鼻咽喉 | 23837篇 |
儿科学 | 50609篇 |
妇产科学 | 38125篇 |
基础医学 | 191232篇 |
口腔科学 | 36058篇 |
临床医学 | 141282篇 |
内科学 | 311908篇 |
皮肤病学 | 35925篇 |
神经病学 | 118942篇 |
特种医学 | 58540篇 |
外国民族医学 | 660篇 |
外科学 | 242359篇 |
综合类 | 27859篇 |
现状与发展 | 73篇 |
一般理论 | 445篇 |
预防医学 | 106115篇 |
眼科学 | 32142篇 |
药学 | 98762篇 |
5篇 | |
中国医学 | 2480篇 |
肿瘤学 | 84638篇 |
出版年
2021年 | 11663篇 |
2019年 | 11993篇 |
2018年 | 20954篇 |
2017年 | 17497篇 |
2016年 | 19527篇 |
2015年 | 21128篇 |
2014年 | 33004篇 |
2013年 | 42796篇 |
2012年 | 44681篇 |
2011年 | 47103篇 |
2010年 | 34445篇 |
2009年 | 36930篇 |
2008年 | 45515篇 |
2007年 | 46626篇 |
2006年 | 49152篇 |
2005年 | 45585篇 |
2004年 | 43871篇 |
2003年 | 41655篇 |
2002年 | 40816篇 |
2001年 | 67886篇 |
2000年 | 69629篇 |
1999年 | 59798篇 |
1998年 | 19077篇 |
1997年 | 17408篇 |
1996年 | 17653篇 |
1995年 | 16754篇 |
1994年 | 14829篇 |
1993年 | 13485篇 |
1992年 | 46035篇 |
1991年 | 44961篇 |
1990年 | 43386篇 |
1989年 | 41352篇 |
1988年 | 38021篇 |
1987年 | 37214篇 |
1986年 | 34614篇 |
1985年 | 33135篇 |
1984年 | 24843篇 |
1983年 | 20962篇 |
1982年 | 12465篇 |
1981年 | 11324篇 |
1979年 | 21736篇 |
1978年 | 15257篇 |
1977年 | 13014篇 |
1976年 | 11982篇 |
1975年 | 12937篇 |
1974年 | 14936篇 |
1973年 | 14385篇 |
1972年 | 13253篇 |
1971年 | 11960篇 |
1970年 | 11321篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctive therapy, were observed for 1 year in 202 adult patients, aged 17-83 years, with newly diagnosed or refractory partial epilepsy in clinical practice in Italy. At first observation, the seizure free rate was 72.2% in newly diagnosed patients given monotherapy, 40% in patients in whom oxcarbazepine replaced another monotherapy and 10.3% in patients given oxcarbazepine as adjunctive therapy. At least 50% reduction in seizure frequency was achieved in 90.7, 72 and 57%, respectively. Efficacy increased with the duration of treatment (p < 0.0001). In the 160 completers the seizure free rate was 61.3% with monotherapy and 28% with adjunctive therapy. 16.3% of patients reported adverse effects, mainly sedation and sleepiness; 5% discontinued oxcarbazepine because of adverse events. OXC is an effective and well-tolerated antiepileptic agent for the long-term treatment of partial epilepsy in adults. 相似文献
73.
74.
75.
Genomes of some parasites contain dozens of alternative and highly diverged surface antigens, of which only a single one is expressed in any cell. Individual cells occasionally change expression of their surface antigen, allowing them to escape immune surveillance. These switches appear to occur in a partly random way, creating a diverse set of antigenic variants. In spite of this diversity, the parasitemia develops as a series of outbreaks, in which each outbreak is dominated by relatively few antigenic types. Host-specific immunity eventually clears the dominant antigenic types, and a new outbreak follows from antigenic types that have apparently been present all along at low frequency. This pattern of sequential dominance by different antigenic types remains unexplained. We review the five most prominent theories, which have developed mainly from studies of the protozoans Trypanosoma and Plasmodium, and the bacterial spirochete Borrelia. The most promising theories depend on some combination of mechanisms to create favored connectivity pathways through the matrix of transitions between variants. Favored pathways may arise from biased switches at the molecular level of gene expression or from biases imposed by immune selection. We illustrate the concept of connectivity pathways by reanalysis of data on transitions between variants from Borrelia hermsii. 相似文献
76.
Lucia Nogovà MD Volker Diehl MD Andreas Engert MD 《Current hematologic malignancy reports》2006,1(1):60-65
Lymphocyte-predominant Hodgkin’s lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin’s
lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin’s lymphoma protocols leads to complete remission in more
than 95% of patients. Survival and freedom from treatment failure are substantially worse in advanced-stage patients than
for early-stage patients. Thus, patients in advanced stages and those in early stages with unfavorable risk factors should
be treated similar to those with cHL. In contrast, patients with early-stage LPHL without risk factors might be sufficiently
treated with reduced-intensity programs having less severe adverse effects. As a result, treatment of early LPHL is rather
heterogeneous, including radiotherapy using extended-fleld technique, involved-fleld radiotherapy (IF-RT), combined-modality
treatment, and, more recently, monoclonal antibodies. Watch-and-wait strategy plays an important role in pediatric oncology,
to avoid adverse effects associated with therapy. IF-RT seems to be emerging as a treatment of choice for patients with stage
IA LPHL; most larger study groups, such as the German Hodgkin Study Group and the European Organisation for Research and Treatment
of Cancer, have adopted IF-RT as the treatment of choice for these patients. 相似文献
77.
78.
79.
80.
K P Sylvester S R Desai A U Wells D M Hansell M Awogbade S L Thein A Greenough 《The European respiratory journal》2006,28(4):832-838
The aim of this study was to determine whether patients with sickle cell disease (SCD) in steady state had pulmonary abnormalities seen on high-resolution computed tomography (HRCT) and whether any abnormalities correlated with contemporaneously diagnosed lung function abnormalities. A subsidiary question was whether the results of a noninvasive measure of haemolysis (end-tidal carbon monoxide (ETCO) levels) correlated with pulmonary function abnormalities. Thirty three patients with SCD, median (range) age 36 yrs (17-67 yrs) were examined. The degree of lobar volume loss and ground-glass opacification and prominence of central vessels on HRCT were quantitatively assessed. Pulmonary function was assessed by measurements of lung volumes, spirometry, gas transfer and oxygen saturation. ETCO levels were measured using an end-tidal CO monitor. Forced expiratory volume in one second (FEV1), forced vital capacity and total lung capacity significantly correlated with HRCT findings, particularly lobar volume loss. ETCO levels significantly negatively correlated with FEV1, vital capacity measured using a plethysmograph, specific airway conductance and arterial oxygen saturation measured by pulse oxymetry. In conclusion, the present results suggest that high-resolution computed tomography noninvasive assessment of haemolysis might be useful to identify sickle cell disease patients with respiratory function impairment. 相似文献